Related Articles
Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study
A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma
Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional study
Granulocyte macrophage colony‑stimulating factor as a predictor of the response of metastatic renal cell carcinoma to tyrosine kinase inhibitor therapy
QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis